跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
C-172
首页
药物
C-172
C-172
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
COMPOSITIONS AND METHODS FOR TREATING CELIAC SPRUE DISEASE
申请人: UNIV WASHINGTON
优先权: 2015
EP
US
WO
8 件公开
Expression of bacterial potassium channels in eukaryotic host cells and their use for the identification of antibiotics
申请人: FORSCHUNGSGESELLSCHAFT GENION
优先权: 1999
EP
Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
申请人: SCHEER HUGO
优先权: 1999
US
ANTI-CRP ANTIBODY AND UTILIZATION OF THE SAME
申请人: UNIV NIHON
优先权: 2008
US
Dextral ibuprofen arginine and preparation method thereof
申请人: JIAAN WU
优先权: 2011
CN
Preparation method of ethyl 2-amino-4-methylthiazole-5-carboxylate
申请人: SHANDONG HUIHAI PHARMACEUTICALS & CHEMICALS CO LTD
优先权: 2013
CN
IL-2 RECEPTOR BINDING COMPOUNDS
申请人: MEDIKINE INC
优先权: 2018
EP
Novel crystal type of DPP-IV inhibitor hypoglycemic drug and preparation method of novel crystal type
申请人: SHANGHAI DESANO PHARMACEUTICALS CO LTD
优先权: 2018
CN
Method for recycling production residue of lactide
申请人: SHOUGUANG JINYUANDONG DENATURED STARCH CO LTD
优先权: 2018
CN
Application of bis-pyridone hydrazone-N-methyl-3-indolylformaldehyde Schiff base
申请人: UNIV QILU TECHNOLOGY
优先权: 2021
CN
第 1 / 2 页
上一页
下一页
药物
反馈